Evidence map›Paper›PMID 42581566›Full record

ArticleAdvanced healthcare materials2026

Amelioration of Cisplatin Nephrotoxicity by Fe-Pt Coordination Exchange-Triggered Ferroptosis Suppression.

Tiantian Chen, Panyu Du, Yuning Liu, Xuefei Chen, Zheng Wang, Xin Li, Xiujie Zhao, Yanjun Zhao

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tiantian ChenSchool of Pharmaceutical Science and Technology, Tianjin Key Laboratory for Modern Drug Delivery and High Efficiency, Faculty of Medicine, Tianjin University, Tianjin, China.
Panyu DuSchool of Pharmaceutical Science and Technology, Tianjin Key Laboratory for Modern Drug Delivery and High Efficiency, Faculty of Medicine, Tianjin University, Tianjin, China.
Yuning LiuSchool of Pharmaceutical Science and Technology, Tianjin Key Laboratory for Modern Drug Delivery and High Efficiency, Faculty of Medicine, Tianjin University, Tianjin, China.
Xuefei ChenSchool of Pharmaceutical Science and Technology, Tianjin Key Laboratory for Modern Drug Delivery and High Efficiency, Faculty of Medicine, Tianjin University, Tianjin, China.
Zheng WangSchool of Pharmaceutical Science and Technology, Tianjin Key Laboratory for Modern Drug Delivery and High Efficiency, Faculty of Medicine, Tianjin University, Tianjin, China.
Xin LiSchool of Pharmaceutical Science and Technology, Tianjin Key Laboratory for Modern Drug Delivery and High Efficiency, Faculty of Medicine, Tianjin University, Tianjin, China.ORCID https://orcid.org/0000-0001-6044-6782
Xiujie ZhaoSchool of Pharmaceutical Science and Technology, Tianjin Key Laboratory for Modern Drug Delivery and High Efficiency, Faculty of Medicine, Tianjin University, Tianjin, China.ORCID https://orcid.org/0000-0001-9267-0252
Yanjun ZhaoSchool of Pharmaceutical Science and Technology, Tianjin Key Laboratory for Modern Drug Delivery and High Efficiency, Faculty of Medicine, Tianjin University, Tianjin, China.ORCID https://orcid.org/0000-0001-5739-1960

Funding

National Natural Science Foundation of China 22175130Tianjin Natural Science Foundation 24JCQNJC01740
6 · The paper itself

Abstract

Ferroptosis is an iron-dependent form of regulated cell death that has emerged as one of the mechanisms underlying cisplatin-induced nephrotoxicity. Here, we report an iron-chelating polymeric micelle for controlled cisplatin activation and ferroptosis suppression to address the above issue. The block copolymer, methoxyl polyethylene glycol-poly(glutamic acid) (mPEG-PGlu) was coupled with an iron chelator, deferiprone (Dfp) to generate the tailored amphiphilic conjugate, mPEG-P(Glu-Dfp) that could coordinate with activated cisplatin and self-assemble into micelles (Pt@M

Indexed as

CisplatinFerroptosisIronPlatinumAnimalsCell Line, TumorDeferiproneFemaleHumansIron Chelating AgentsKidneyMiceMice, Inbred BALB CMicellesPolyethylene GlycolsPolyglutamic AcidCisplatinDeferiproneIronIron Chelating AgentsMicellesmonomethoxypolyethylene glycolPlatinumPolyethylene GlycolsPolyglutamic Acidcisplatin nephrotoxicitycontrolled releasedrug deliveryferroptosismicelles

Identifiers

PMID42581566
PMCPMC13569017

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.